 | • レポートコード：QFJ1-5044 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、全ゲノム＆エクソームシーケンスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キット、機器）、用途別市場規模（病院・診療所、製薬・バイオテクノロジー企業、診断研究所、研究センター、学術・政府機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・全ゲノム＆エクソームシーケンスの市場動向 ・企業の競争状況、市場シェア ・全ゲノム＆エクソームシーケンスの種類別市場規模と予測2016-2027（キット、機器） ・全ゲノム＆エクソームシーケンスの用途別市場規模と予測2016-2027（病院・診療所、製薬・バイオテクノロジー企業、診断研究所、研究センター、学術・政府機関、その他） ・全ゲノム＆エクソームシーケンスの北米市場規模2016-2027（アメリカ、カナダ） ・全ゲノム＆エクソームシーケンスの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・全ゲノム＆エクソームシーケンスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・全ゲノム＆エクソームシーケンスの中南米市場規模2016-2027（メキシコ、ブラジル） ・全ゲノム＆エクソームシーケンスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eurofins Scientific SE、Agilent Technologies, Inc、Beijing Genomics Institute (BGI)、Hoffmann-La Roche Ltd、Bio-Rad Laboratories, Inc、GENEWIZ, Inc、Illumina, Inc、Laboratory Corporation of America Holdings、Novogene Corporation、Oxford Nanopore Technologies, Inc、Pacific Biosciences of California, Inc、QIAGEN N.V、Thermo Fisher Scientific Inc、Cytiva） ・結論 |
Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers to generate large quantities of data, which can then be analyzed.The exome makes up only 1.5% of the whole human genome, however ALL protein coding genes are found in the exome. Since most genetic disorders are correlated with mutations in protein coding genes, most physicians and scientists who use sequencing technologies for diagnostic purposes start with an analysis of the exome.
Market Analysis and Insights: Global Whole Genome and Exome Sequencing Market
The global Whole Genome and Exome Sequencing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Whole Genome and Exome Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Whole Genome and Exome Sequencing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Whole Genome and Exome Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Whole Genome and Exome Sequencing market.
Global Whole Genome and Exome Sequencing Scope and Market Size
Whole Genome and Exome Sequencing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Whole Genome and Exome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
By Product
Kits
Instruments
By Workflow
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Segment by Application
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Whole Genome and Exome Sequencing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Kits
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Whole Genome and Exome Sequencing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Diagnostic Labs
1.3.5 Research Centres, Academia and Government Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Whole Genome and Exome Sequencing Market Perspective (2016-2027)
2.2 Whole Genome and Exome Sequencing Growth Trends by Regions
2.2.1 Whole Genome and Exome Sequencing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Whole Genome and Exome Sequencing Historic Market Share by Regions (2016-2021)
2.2.3 Whole Genome and Exome Sequencing Forecasted Market Size by Regions (2022-2027)
2.3 Whole Genome and Exome Sequencing Industry Dynamic
2.3.1 Whole Genome and Exome Sequencing Market Trends
2.3.2 Whole Genome and Exome Sequencing Market Drivers
2.3.3 Whole Genome and Exome Sequencing Market Challenges
2.3.4 Whole Genome and Exome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Whole Genome and Exome Sequencing Players by Revenue
3.1.1 Global Top Whole Genome and Exome Sequencing Players by Revenue (2016-2021)
3.1.2 Global Whole Genome and Exome Sequencing Revenue Market Share by Players (2016-2021)
3.2 Global Whole Genome and Exome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Whole Genome and Exome Sequencing Revenue
3.4 Global Whole Genome and Exome Sequencing Market Concentration Ratio
3.4.1 Global Whole Genome and Exome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Genome and Exome Sequencing Revenue in 2020
3.5 Whole Genome and Exome Sequencing Key Players Head office and Area Served
3.6 Key Players Whole Genome and Exome Sequencing Product Solution and Service
3.7 Date of Enter into Whole Genome and Exome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Genome and Exome Sequencing Breakdown Data by Type
4.1 Global Whole Genome and Exome Sequencing Historic Market Size by Type (2016-2021)
4.2 Global Whole Genome and Exome Sequencing Forecasted Market Size by Type (2022-2027)
5 Whole Genome and Exome Sequencing Breakdown Data by Application
5.1 Global Whole Genome and Exome Sequencing Historic Market Size by Application (2016-2021)
5.2 Global Whole Genome and Exome Sequencing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Whole Genome and Exome Sequencing Market Size (2016-2027)
6.2 North America Whole Genome and Exome Sequencing Market Size by Type
6.2.1 North America Whole Genome and Exome Sequencing Market Size by Type (2016-2021)
6.2.2 North America Whole Genome and Exome Sequencing Market Size by Type (2022-2027)
6.2.3 North America Whole Genome and Exome Sequencing Market Size by Type (2016-2027)
6.3 North America Whole Genome and Exome Sequencing Market Size by Application
6.3.1 North America Whole Genome and Exome Sequencing Market Size by Application (2016-2021)
6.3.2 North America Whole Genome and Exome Sequencing Market Size by Application (2022-2027)
6.3.3 North America Whole Genome and Exome Sequencing Market Size by Application (2016-2027)
6.4 North America Whole Genome and Exome Sequencing Market Size by Country
6.4.1 North America Whole Genome and Exome Sequencing Market Size by Country (2016-2021)
6.4.2 North America Whole Genome and Exome Sequencing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Whole Genome and Exome Sequencing Market Size (2016-2027)
7.2 Europe Whole Genome and Exome Sequencing Market Size by Type
7.2.1 Europe Whole Genome and Exome Sequencing Market Size by Type (2016-2021)
7.2.2 Europe Whole Genome and Exome Sequencing Market Size by Type (2022-2027)
7.2.3 Europe Whole Genome and Exome Sequencing Market Size by Type (2016-2027)
7.3 Europe Whole Genome and Exome Sequencing Market Size by Application
7.3.1 Europe Whole Genome and Exome Sequencing Market Size by Application (2016-2021)
7.3.2 Europe Whole Genome and Exome Sequencing Market Size by Application (2022-2027)
7.3.3 Europe Whole Genome and Exome Sequencing Market Size by Application (2016-2027)
7.4 Europe Whole Genome and Exome Sequencing Market Size by Country
7.4.1 Europe Whole Genome and Exome Sequencing Market Size by Country (2016-2021)
7.4.2 Europe Whole Genome and Exome Sequencing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Whole Genome and Exome Sequencing Market Size (2016-2027)
8.2 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Type
8.2.1 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Type (2016-2027)
8.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Application
8.3.1 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Application (2016-2027)
8.4 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region
8.4.1 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Whole Genome and Exome Sequencing Market Size (2016-2027)
9.2 Latin America Whole Genome and Exome Sequencing Market Size by Type
9.2.1 Latin America Whole Genome and Exome Sequencing Market Size by Type (2016-2021)
9.2.2 Latin America Whole Genome and Exome Sequencing Market Size by Type (2022-2027)
9.2.3 Latin America Whole Genome and Exome Sequencing Market Size by Type (2016-2027)
9.3 Latin America Whole Genome and Exome Sequencing Market Size by Application
9.3.1 Latin America Whole Genome and Exome Sequencing Market Size by Application (2016-2021)
9.3.2 Latin America Whole Genome and Exome Sequencing Market Size by Application (2022-2027)
9.3.3 Latin America Whole Genome and Exome Sequencing Market Size by Application (2016-2027)
9.4 Latin America Whole Genome and Exome Sequencing Market Size by Country
9.4.1 Latin America Whole Genome and Exome Sequencing Market Size by Country (2016-2021)
9.4.2 Latin America Whole Genome and Exome Sequencing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Whole Genome and Exome Sequencing Market Size (2016-2027)
10.2 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Type
10.2.1 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Type (2016-2027)
10.3 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Application
10.3.1 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Application (2016-2027)
10.4 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country
10.4.1 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eurofins Scientific SE
11.1.1 Eurofins Scientific SE Company Details
11.1.2 Eurofins Scientific SE Business Overview
11.1.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Introduction
11.1.4 Eurofins Scientific SE Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.1.5 Eurofins Scientific SE Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Details
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Whole Genome and Exome Sequencing Introduction
11.2.4 Agilent Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Beijing Genomics Institute (BGI)
11.3.1 Beijing Genomics Institute (BGI) Company Details
11.3.2 Beijing Genomics Institute (BGI) Business Overview
11.3.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Introduction
11.3.4 Beijing Genomics Institute (BGI) Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.3.5 Beijing Genomics Institute (BGI) Recent Development
11.4 Hoffmann-La Roche Ltd
11.4.1 Hoffmann-La Roche Ltd Company Details
11.4.2 Hoffmann-La Roche Ltd Business Overview
11.4.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Introduction
11.4.4 Hoffmann-La Roche Ltd Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.4.5 Hoffmann-La Roche Ltd Recent Development
11.5 Bio-Rad Laboratories, Inc
11.5.1 Bio-Rad Laboratories, Inc Company Details
11.5.2 Bio-Rad Laboratories, Inc Business Overview
11.5.3 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Introduction
11.5.4 Bio-Rad Laboratories, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.5.5 Bio-Rad Laboratories, Inc Recent Development
11.6 GENEWIZ, Inc
11.6.1 GENEWIZ, Inc Company Details
11.6.2 GENEWIZ, Inc Business Overview
11.6.3 GENEWIZ, Inc Whole Genome and Exome Sequencing Introduction
11.6.4 GENEWIZ, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.6.5 GENEWIZ, Inc Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Details
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Whole Genome and Exome Sequencing Introduction
11.7.4 Illumina, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.7.5 Illumina, Inc Recent Development
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Company Details
11.8.2 Laboratory Corporation of America Holdings Business Overview
11.8.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Introduction
11.8.4 Laboratory Corporation of America Holdings Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.8.5 Laboratory Corporation of America Holdings Recent Development
11.9 Novogene Corporation
11.9.1 Novogene Corporation Company Details
11.9.2 Novogene Corporation Business Overview
11.9.3 Novogene Corporation Whole Genome and Exome Sequencing Introduction
11.9.4 Novogene Corporation Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.9.5 Novogene Corporation Recent Development
11.10 Oxford Nanopore Technologies, Inc
11.10.1 Oxford Nanopore Technologies, Inc Company Details
11.10.2 Oxford Nanopore Technologies, Inc Business Overview
11.10.3 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Introduction
11.10.4 Oxford Nanopore Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.10.5 Oxford Nanopore Technologies, Inc Recent Development
11.11 Pacific Biosciences of California, Inc
11.11.1 Pacific Biosciences of California, Inc Company Details
11.11.2 Pacific Biosciences of California, Inc Business Overview
11.11.3 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Introduction
11.11.4 Pacific Biosciences of California, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.11.5 Pacific Biosciences of California, Inc Recent Development
11.12 QIAGEN N.V
11.12.1 QIAGEN N.V Company Details
11.12.2 QIAGEN N.V Business Overview
11.12.3 QIAGEN N.V Whole Genome and Exome Sequencing Introduction
11.12.4 QIAGEN N.V Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.12.5 QIAGEN N.V Recent Development
11.13 Thermo Fisher Scientific Inc
11.13.1 Thermo Fisher Scientific Inc Company Details
11.13.2 Thermo Fisher Scientific Inc Business Overview
11.13.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Introduction
11.13.4 Thermo Fisher Scientific Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.13.5 Thermo Fisher Scientific Inc Recent Development
11.14 Cytiva
11.14.1 Cytiva Company Details
11.14.2 Cytiva Business Overview
11.14.3 Cytiva Whole Genome and Exome Sequencing Introduction
11.14.4 Cytiva Revenue in Whole Genome and Exome Sequencing Business (2016-2021)
11.14.5 Cytiva Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Whole Genome and Exome Sequencing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Kits
Table 3. Key Players of Instruments
Table 4. Global Whole Genome and Exome Sequencing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Whole Genome and Exome Sequencing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Whole Genome and Exome Sequencing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Whole Genome and Exome Sequencing Market Share by Regions (2016-2021)
Table 8. Global Whole Genome and Exome Sequencing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Whole Genome and Exome Sequencing Market Share by Regions (2022-2027)
Table 10. Whole Genome and Exome Sequencing Market Trends
Table 11. Whole Genome and Exome Sequencing Market Drivers
Table 12. Whole Genome and Exome Sequencing Market Challenges
Table 13. Whole Genome and Exome Sequencing Market Restraints
Table 14. Global Whole Genome and Exome Sequencing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Whole Genome and Exome Sequencing Market Share by Players (2016-2021)
Table 16. Global Top Whole Genome and Exome Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Whole Genome and Exome Sequencing as of 2020)
Table 17. Ranking of Global Top Whole Genome and Exome Sequencing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Whole Genome and Exome Sequencing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Whole Genome and Exome Sequencing Product Solution and Service
Table 21. Date of Enter into Whole Genome and Exome Sequencing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Whole Genome and Exome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2016-2021)
Table 25. Global Whole Genome and Exome Sequencing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Whole Genome and Exome Sequencing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2016-2021)
Table 29. Global Whole Genome and Exome Sequencing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Whole Genome and Exome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Whole Genome and Exome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Whole Genome and Exome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Whole Genome and Exome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Whole Genome and Exome Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Whole Genome and Exome Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Whole Genome and Exome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Whole Genome and Exome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Whole Genome and Exome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Whole Genome and Exome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Whole Genome and Exome Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Whole Genome and Exome Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Whole Genome and Exome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Whole Genome and Exome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Whole Genome and Exome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Whole Genome and Exome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Whole Genome and Exome Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Whole Genome and Exome Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eurofins Scientific SE Company Details
Table 62. Eurofins Scientific SE Business Overview
Table 63. Eurofins Scientific SE Whole Genome and Exome Sequencing Product
Table 64. Eurofins Scientific SE Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 65. Eurofins Scientific SE Recent Development
Table 66. Agilent Technologies, Inc Company Details
Table 67. Agilent Technologies, Inc Business Overview
Table 68. Agilent Technologies, Inc Whole Genome and Exome Sequencing Product
Table 69. Agilent Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 70. Agilent Technologies, Inc Recent Development
Table 71. Beijing Genomics Institute (BGI) Company Details
Table 72. Beijing Genomics Institute (BGI) Business Overview
Table 73. Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product
Table 74. Beijing Genomics Institute (BGI) Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 75. Beijing Genomics Institute (BGI) Recent Development
Table 76. Hoffmann-La Roche Ltd Company Details
Table 77. Hoffmann-La Roche Ltd Business Overview
Table 78. Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product
Table 79. Hoffmann-La Roche Ltd Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 80. Hoffmann-La Roche Ltd Recent Development
Table 81. Bio-Rad Laboratories, Inc Company Details
Table 82. Bio-Rad Laboratories, Inc Business Overview
Table 83. Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product
Table 84. Bio-Rad Laboratories, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 85. Bio-Rad Laboratories, Inc Recent Development
Table 86. GENEWIZ, Inc Company Details
Table 87. GENEWIZ, Inc Business Overview
Table 88. GENEWIZ, Inc Whole Genome and Exome Sequencing Product
Table 89. GENEWIZ, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 90. GENEWIZ, Inc Recent Development
Table 91. Illumina, Inc Company Details
Table 92. Illumina, Inc Business Overview
Table 93. Illumina, Inc Whole Genome and Exome Sequencing Product
Table 94. Illumina, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 95. Illumina, Inc Recent Development
Table 96. Laboratory Corporation of America Holdings Company Details
Table 97. Laboratory Corporation of America Holdings Business Overview
Table 98. Laboratory Corporation of America Holdings Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 99. Laboratory Corporation of America Holdings Recent Development
Table 100. Novogene Corporation Company Details
Table 101. Novogene Corporation Business Overview
Table 102. Novogene Corporation Whole Genome and Exome Sequencing Product
Table 103. Novogene Corporation Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 104. Novogene Corporation Recent Development
Table 105. Oxford Nanopore Technologies, Inc Company Details
Table 106. Oxford Nanopore Technologies, Inc Business Overview
Table 107. Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product
Table 108. Oxford Nanopore Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 109. Oxford Nanopore Technologies, Inc Recent Development
Table 110. Pacific Biosciences of California, Inc Company Details
Table 111. Pacific Biosciences of California, Inc Business Overview
Table 112. Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product
Table 113. Pacific Biosciences of California, Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 114. Pacific Biosciences of California, Inc Recent Development
Table 115. QIAGEN N.V Company Details
Table 116. QIAGEN N.V Business Overview
Table 117. QIAGEN N.V Whole Genome and Exome Sequencing Product
Table 118. QIAGEN N.V Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 119. QIAGEN N.V Recent Development
Table 120. Thermo Fisher Scientific Inc Company Details
Table 121. Thermo Fisher Scientific Inc Business Overview
Table 122. Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product
Table 123. Thermo Fisher Scientific Inc Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 124. Thermo Fisher Scientific Inc Recent Development
Table 125. Cytiva Company Details
Table 126. Cytiva Business Overview
Table 127. Cytiva Whole Genome and Exome Sequencing Product
Table 128. Cytiva Revenue in Whole Genome and Exome Sequencing Business (2016-2021) & (US$ Million)
Table 129. Cytiva Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Whole Genome and Exome Sequencing Market Share by Type: 2020 VS 2027
Figure 2. Kits Features
Figure 3. Instruments Features
Figure 4. Global Whole Genome and Exome Sequencing Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Pharmaceutical and Biotechnology Companies Case Studies
Figure 7. Diagnostic Labs Case Studies
Figure 8. Research Centres, Academia and Government Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Whole Genome and Exome Sequencing Report Years Considered
Figure 11. Global Whole Genome and Exome Sequencing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Whole Genome and Exome Sequencing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Whole Genome and Exome Sequencing Market Share by Regions: 2020 VS 2027
Figure 14. Global Whole Genome and Exome Sequencing Market Share by Regions (2022-2027)
Figure 15. Global Whole Genome and Exome Sequencing Market Share by Players in 2020
Figure 16. Global Top Whole Genome and Exome Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Whole Genome and Exome Sequencing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Whole Genome and Exome Sequencing Revenue in 2020
Figure 18. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2016-2021)
Figure 19. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2022-2027)
Figure 20. North America Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Whole Genome and Exome Sequencing Market Share by Type (2016-2027)
Figure 22. North America Whole Genome and Exome Sequencing Market Share by Application (2016-2027)
Figure 23. North America Whole Genome and Exome Sequencing Market Share by Country (2016-2027)
Figure 24. United States Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Whole Genome and Exome Sequencing Market Share by Type (2016-2027)
Figure 28. Europe Whole Genome and Exome Sequencing Market Share by Application (2016-2027)
Figure 29. Europe Whole Genome and Exome Sequencing Market Share by Country (2016-2027)
Figure 30. Germany Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Whole Genome and Exome Sequencing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Whole Genome and Exome Sequencing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Whole Genome and Exome Sequencing Market Share by Region (2016-2027)
Figure 40. China Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Whole Genome and Exome Sequencing Market Share by Type (2016-2027)
Figure 48. Latin America Whole Genome and Exome Sequencing Market Share by Application (2016-2027)
Figure 49. Latin America Whole Genome and Exome Sequencing Market Share by Country (2016-2027)
Figure 50. Mexico Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Whole Genome and Exome Sequencing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Whole Genome and Exome Sequencing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Whole Genome and Exome Sequencing Market Share by Country (2016-2027)
Figure 56. Turkey Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Whole Genome and Exome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eurofins Scientific SE Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 60. Agilent Technologies, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 61. Beijing Genomics Institute (BGI) Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 62. Hoffmann-La Roche Ltd Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 63. Bio-Rad Laboratories, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 64. GENEWIZ, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 65. Illumina, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 66. Laboratory Corporation of America Holdings Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 67. Novogene Corporation Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 68. Oxford Nanopore Technologies, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 69. Pacific Biosciences of California, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 70. QIAGEN N.V Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 71. Thermo Fisher Scientific Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 72. Cytiva Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の全ゲノムシーケンシング（WGS）市場規模・現状・予測（2021年-2027年） Whole-genome sequencing (WGS) is the analysis of the entire genomic DNA sequence of a cell at a single time, providing the most comprehensive characterization of the genome. Market Analysis and Insights: Global Whole Genome Sequencing (WGS) Market The global Whole Genome Sequencing (WGS) market size…- ゲノムシーケンシング装置のグローバル市場調査 2019年 The global Genome Sequencing Equipment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Genome Sequencing Equipment volume and value at global level, regional level and company level. From a global p…
- 世界のmRNAシーケンシング市場規模・現状・予測（2021年-2027年） mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify b…
- 世界の全トランスクリプトミクスシーケンシング市場規模・現状・予測（2021年-2027年） Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. Market Analysis and Insights: Global Whole Transcriptomics Sequencing Market The global Whole Transcriptomics Sequencing market size is projected to reach US$ X…
- 世界の全体数シーケンシング市場規模・現状・予測（2021年-2027年） Population-Sequencing is the use of probabilistic matching tools in combination with large volumes of sequence information to identify genomes present, based on DNA analysis across entire genomes to determine genome assignments, to calculate confidence scores of major and minor genome content. Marke…